U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07172334) titled 'What is the Role of the Exposome in Pulmonary Hypertension' on Sept. 03.
Brief Summary: Pulmonary arterial hypertension (PAH) is a rare and incurable disease affecting people of all ages. It is characterized by obstructive remodeling of the small pulmonary arteries, responsible for an increase in pulmonary arterial pressure, leading to right heart failure and death in the absence of treatment. PAH can be associated with a variety of diseases, but around half of all PAH cases are idiopathic or hereditary, and may develop on predisposed terrain following a "second hit", as suggested by the identification of PAH cases associated with ...